If you're having trouble viewing this email, see it on the Web.
Technet21

Home | Invite Others | Digest Archives  

Posts:

technet21 postspacerReport on Intradermal Delivery of Vaccines

technet21 postspacerRedesigned Immunization Card

technet21 postspacerProgress Towards a Heat and Freeze–Stable Hepatitis B Vaccine

Issue 20, 14 September 2009

 
Editorial Note

Debra Kristensen posts a report assessing the potential of intradermal vaccine delivery. TechNet21 members are requested to send in their comments and suggestions.

Tasnim Partapuri shares a study that appeared in Vaccine on how an inexpensive and well–designed immunization card helps reduce vaccine dropouts. Since we are on the subject, do send in images of similar cards that are used in your countries and share related experiences in immunization record keeping.

Debra Kristensen also replies to Steven Wiersma's question regarding heat–stable second generation vaccines.


 by Debra Kristensen

We would like to share a report on intradermal delivery of vaccines that was commissioned by PATH's Disposable Jet Injector Project and Project Optimize ...

The purpose of the report is three–fold:

  1. To summarize the clinical evidence supporting the intradermal route for vaccine administration and the devices being developed for this purpose;
  2. To determine whether intradermal delivery broadly holds promise for vaccine applications for low– and middle–income countries in the future; and
  3. To begin to prioritize vaccine targets and device strategies that best fit the public health needs in these countries and likely merit further investigation.

[Read more]

Comment on this post by email or on the web


 by Tasnim Partapuri

In Pakistan, a small EPI card is used that contains information on the child identification; immunization schedule; information for mothers; and next immunization visit dates. All this information, cluttered on a small card, can make it difficult for generally less literate mothers to locate the item most relevant for them, i.e. their child's next immunization date. In addition, the next immunization date is handwritten and often in such small and irregular letters that it further amplifies the difficulty for mothers to read it. ...

[Read more]

Comment on this post by email or on the web


 by Debra Kristensen

Phase 3 bridging studies comparing the immunogenicity and safety of the new vaccine to the reference vaccine should be the norm to make these types of changes to second–generation vaccine products. We are looking at trials involving between 300 and 500 subjects. Yes, this is a costly endeavour. However, it is important that the stabilization methods be applied to at least a few existing products to pave the way for others.

[Read more]

Comment on this post by email or on the web

Inverted bottles
Photo Courtesy: ITPI
 
bottle in hand
Photo Courtesy: ITPI

  Web Highlights:
  technet21 post E.V–Trax Employee Vaccination Tracking System helps eliminate manual data entry
  technet21 post Oral cholera vaccine Shanchol from Shantha for India
  technet21 post Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa
  technet21 post Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
  technet21 post Principles for allocation of scarce medical interventions

 


Register

 

If you have contributions to make or thoughts to share with others on TechNet21, you can write to the moderator or post directly on the web forums. Click here to change your subscription settings or unsubscribe from the mailing list.

TechNet21 is generously supported by the Bill and Melinda Gates Foundation, under the oversight of WHO and UNICEF. The information in this forum is provided by users, as a service. All contributions are reviewed prior to posting, and all postings are attributed to the authors. The details given in emails will not be voluntarily shared or sold to any outside company and will only be used for verification and to identify postings, if necessary. The authors are solely responsible for their submissions, and the readers are solely responsible for the interpretation of these submissions. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to this forum.

For posts where the author is a WHO staff member, the author alone is reponsible for the views expressed and they do not necessarily represent the decisions, guidelines, recommendations or policies of WHO.